The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA2261382
Max Phase: Preclinical
Molecular Formula: C19H19N3O2
Molecular Weight: 321.38
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: CCc1ccc(CCOc2ccc(C3=NOC(C#N)C3)cc2)nc1
Standard InChI: InChI=1S/C19H19N3O2/c1-2-14-3-6-16(21-13-14)9-10-23-17-7-4-15(5-8-17)19-11-18(12-20)24-22-19/h3-8,13,18H,2,9-11H2,1H3
Standard InChI Key: FRIRPFJDFQKOQM-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 321.38Molecular Weight (Monoisotopic): 321.1477AlogP: 3.28#Rotatable Bonds: 6Polar Surface Area: 67.50Molecular Species: NEUTRALHBA: 5HBD: 0#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 5.64CX LogP: 3.23CX LogD: 3.22Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.82Np Likeness Score: -0.88
References 1. Gaonkar S, Rai KL, Prabhuswamy B. (2006) Synthesis of novel 3-[5-ethyl-2-(2-phenoxy-ethyl)-pyridin]-5-substituted isoxazoline libraries via 1,3-dipolar cycloaddition and evaluation of antimicrobial activities, 15 (7): [10.1007/s00044-006-0015-z ]
